Previous studies demonstrated that the newly group 2 innate lymphoid cell (ILC2) can quickly induce airway eosinophilic inflammation by releasing Th2 cytokines when activated by the epitheliumproducing alarmins in asthma. However, whether ILC2 also plays a role in the airway inflammation of eosinophilic bronchitis (EB) remains unclear. 
Background and Aims:
Previous studies demonstrated that the newly group 2 innate lymphoid cell (ILC2) can quickly induce airway eosinophilic inflammation by releasing Th2 cytokines when activated by the epitheliumproducing alarmins in asthma. However, whether ILC2 also plays a role in the airway inflammation of eosinophilic bronchitis (EB) remains unclear.
Methods: In a follow-up study, we enumerated blood and sputum Methods: General physicians (GPs, N = 603) and paediatricians (N = 601) treating at least 10 asthma patients/month were interviewed in six Asian countries. Physicians were questioned about their knowledge, beliefs and management of patients with coexistent disease.
Results: GPs saw fewer AR patients per month than paediatricians (mean 37 vs 56) but approximately the same number of asthma patients (mean 52 vs 56). Most GPs and paediatricians believed, respectively, that asthma and AR can coexist (82% for both), coexistent disease results in more burdensome symptoms than asthma (83% vs 87%) or AR alone (88% vs 91%), and that both conditions should be managed and treated (92% vs 90%). More paediatricians than GPs said they managed both diseases in patients with coexistent disease (81% vs 69%), and asked about AR symptoms in asthma patients (77% vs 64%) and about asthma symptoms in AR patients (74% vs 68%) at every clinic visit. Although >80% of both physician groups believed that guidelines are sufficient for treating coexistent disease and guideline-recommended inhaled and intranasal corticosteroids can be given concurrently, this combination was prescribed by less than half of all physicians (GPs: 44%, paediatricians: 50%); consistent with the belief that corticosteroids are associated with too many sideeffects (41% vs 34% respectively) and that inhaled and intranasal corticosteroids should be delayed in children (29% vs 20% respectively).
Conclusion: Both GPs and paediatricians recognise the burden of coexistent asthma and AR. In this survey, paediatricians were more likely to treat both conditions separately and had fewer concerns regarding overall steroid used, with the primary aim to achieve disease control for both asthma and AR. Results: 14 patients with EB, 12 patients with EA and 8 healthy volunteers were enrolled in this study. EA had more circulating CD4 + CRTh2 +
